Understanding how certain proteins affect brain health in Alzheimer's disease.

Investigating the regulation of lipid homeostasis and lysosomal function in neurodegenerative disease by prosaposin and progranulin in C. elegans

NIH-funded research University of California, San Francisco · NIH-10936539

This study is looking at two proteins, progranulin and prosaposin, to see how they help keep our brains healthy, especially for people with Alzheimer's and similar conditions, and it hopes to find new ways to treat these diseases.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco NIH-funded
Lab location1 site (San Francisco, United States)
Project IDNIH-10936539 on NIH RePORTER

What this research studies

This research explores the roles of two proteins, progranulin and prosaposin, in maintaining brain health and function, particularly in the context of Alzheimer's disease and related dementias. By studying these proteins in a model organism, C. elegans, the researchers aim to uncover how they influence lipid metabolism and lysosomal function, which are critical for neuronal health. The approach involves genetic and biochemical techniques to analyze the effects of these proteins on cellular processes that may contribute to neurodegenerative diseases. Patients may benefit from insights gained into the biological mechanisms of Alzheimer's disease, potentially leading to new therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of Alzheimer's disease or related dementias, particularly those with genetic mutations affecting progranulin.

Not a fit: Patients with neurodegenerative diseases unrelated to lipid metabolism or lysosomal function may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve brain health and slow the progression of Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the roles of lysosomal proteins in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

San Francisco, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.